April 23, 2020
Incarcerated "pharma bro" Martin Shkreli and his former company Retrophin Inc. have managed to slip claims that they tried to keep a generic competitor to their kidney drug Thiola out of the market, as the would-be rival quietly dropped its suit Wednesday.
April 02, 2020
Incarcerated "pharma bro" Martin Shkreli and his former company Retrophin Inc. are trying once again to convince a Pennsylvania federal judge to let them out of a suit alleging they tried to keep a generic competitor to their kidney drug Thiola out of the market.
April 11, 2019
Incarcerated "pharma bro" Martin Shkreli and his former company Retrophin Inc. failed to convince a Pennsylvania federal judge to toss a suit accusing them of trying to shut out a generic competitor to the kidney drug Thiola.
October 24, 2018
Biopharmaceutical maker Retrophin Inc. and its ousted founder, "pharma bro" Martin Shkreli, have been slammed with an antitrust suit in Pennsylvania federal court accusing them of trying to shut out a generic competitor to the kidney drug Thiola.